CLPT
ClearPoint Neuro, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.30
+6.12%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$10.00
From 52W high−46.97%
Volume71552.00
Market cap$330.30M
P/E (TTM)—
P/S (TTM)7.3x
Div yield—
Key dataNov 4, 2026
Open
$10.00
From 52W high
−46.97%
Volume
71552.00
Market cap
$330.30M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−13.3x
P/E (TTM)
—
RSI (14)
40.8
MomentumView details →
1D Return
+6.12%
YTD Return
−29.09%
SummaryUpdated Sep 1, 2026
ClearPoint Neuro, Inc. (NASDAQ:CLPT) is a medical device company founded in 1998 and headquartered in Solana Beach, California. Originally incorporated as MRI Interventions, Inc., the company changed its name to ClearPoint Neuro in February 2020 to better reflect its focus on neurological applications. The company specializes in developing and commercializing platforms that enable minimally invasive surgical procedures in the brain under direct, real-time magnetic resonance imaging (MRI) guidance. ClearPoint has established itself as a key enabler in the emerging cell and gene therapy market while also serving traditional neurosurgery applications.
Similar companies
Latest newsMore news →
ClearPoint Neuro reported a quarterly loss of $0.24 per share, compared with a loss of $0.21 per share a year earlier.7d agoClearPoint Neuro reported third-quarter 2026 revenue of $12.075 million, up 36% year over year, and a net loss of $7.46 million.7d agoClearPoint Neuro announced that it will release its third-quarter 2026 financial results after the market close on October 28, 2026.21d ago